Loading...
XNYS
CC
Market cap1.51bUSD
Jun 04, Last price  
10.07USD
1D
1.41%
1Q
-28.02%
Jan 2017
-54.41%
IPO
-49.73%
Name

Chemours Co

Chart & Performance

D1W1MN
P/E
17.53
P/S
0.26
EPS
0.57
Div Yield, %
7.45%
Shrs. gr., 5y
-1.86%
Rev. gr., 5y
0.91%
Revenues
5.78b
-4.07%
7,972,000,0007,365,000,0006,859,000,0006,432,000,0005,717,000,0005,400,000,0006,183,000,0006,638,000,0005,526,000,0004,969,000,0006,345,000,0006,794,000,0006,027,000,0005,782,000,000
Net income
86m
P
1,431,000,0001,057,000,000423,000,000400,000,000-90,000,0007,000,000746,000,000995,000,000-52,000,000219,000,000608,000,000578,000,000-238,000,00086,000,000
CFO
-633m
L
1,496,000,0001,390,000,000798,000,000505,000,000182,000,000594,000,000639,000,0001,140,000,000650,000,000807,000,000820,000,000754,000,000556,000,000-633,000,000
Dividend
Aug 15, 20240.25 USD/sh
Earnings
Jul 30, 2025

Profile

The Chemours Co. is a holding company, which engages in the provision of performance chemicals. The company is headquartered in Wilmington, Delaware and currently employs 7,000 full-time employees. The firm operates through three segments: Titanium Technologies, Fluoroproducts and Chemical Solutions. The Titanium Technologies segment is a producer of titanium dioxide (TiO2). The Fluoroproducts segment is a provider of fluoroproducts, including refrigerants and industrial fluoropolymer resins. The Chemical Solutions segment is a North American provider of industrial chemicals used in gold production, oil and gas, water treatment and other industries. The company delivers customized solutions with a range of industrial and specialty chemical products for markets, including plastics and coatings, refrigeration and air conditioning, industrial, mining and oil refining. Its products include titanium dioxide, refrigerants, industrial fluoropolymer resins and a portfolio of mining and industrial chemicals, including sodium cyanide. As of December 31, 2016, the Company operates 26 production facilities located in 10 countries.
URL
https://www.chemours.com/
IPO date
Jun 19, 2015
Employees
6,600
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
5,782,000
-4.07%
6,027,000
-11.29%
6,794,000
7.08%
Cost of revenue
4,740,000
4,829,000
5,296,000
Unusual Expense (Income)
NOPBT
1,042,000
1,198,000
1,498,000
NOPBT Margin
18.02%
19.88%
22.05%
Operating Taxes
41,000
(81,000)
163,000
Tax Rate
3.93%
10.88%
NOPAT
1,001,000
1,279,000
1,335,000
Net income
86,000
-136.13%
(238,000)
-141.18%
578,000
-4.93%
Dividends
(148,000)
(149,000)
(154,000)
Dividend yield
5.84%
3.17%
3.18%
Proceeds from repurchase of equity
(69,000)
(444,000)
BB yield
1.47%
9.16%
Debt
Debt current
54,000
106,000
25,000
Long-term debt
4,442,000
4,408,000
3,986,000
Deferred revenue
Other long-term liabilities
824,000
835,000
793,000
Net debt
3,631,000
3,153,000
2,734,000
Cash flow
Cash from operating activities
(633,000)
556,000
754,000
CAPEX
(360,000)
(370,000)
(307,000)
Cash from investing activities
(353,000)
(229,000)
(284,000)
Cash from financing activities
(36,000)
172,000
(685,000)
FCF
708,000
1,180,000
1,120,000
Balance
Cash
713,000
1,203,000
1,102,000
Long term investments
152,000
158,000
175,000
Excess cash
575,900
1,059,650
937,300
Stockholders' equity
1,354,000
1,512,000
1,829,000
Invested Capital
5,155,100
4,767,350
4,733,700
ROIC
20.18%
26.92%
29.55%
ROCE
18.07%
20.41%
26.13%
EV
Common stock shares outstanding
150,014
148,912
158,303
Price
16.90
-46.42%
31.54
3.00%
30.62
-8.76%
Market cap
2,535,230
-46.02%
4,696,697
-3.11%
4,847,238
-14.38%
EV
6,167,230
7,851,697
7,581,238
EBITDA
1,343,000
1,505,000
1,789,000
EV/EBITDA
4.59
5.22
4.24
Interest
264,000
208,000
163,000
Interest/NOPBT
25.34%
17.36%
10.88%